You're reading the free version. Trader adds the live tape and alerts.
Start tracking
HALO Exercise Disclosure
Torley Helen · SEC Form 4 · Filed Jun 3, 2026
Exercise
Calculated transaction value
$241.4K
Torley Helen President And CEO
HALO
Transaction date
Jun 1, 2026
Public filing date
Jun 3, 2026
Filing lag
Filed 2 days later
HALO daily price context
Close on/before transaction
$68.14
Jun 1, 2026
First close after public filing
--
Unavailable
30-day return after filing
--
Through Unavailable
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Option to Purchase Common Stock on Common Stock
- Quantity / price
- 20,000 shares @ $12.07
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0001159036-26-000074
Filing cohort
Transactions in this filing
Showing 15 of 15
Trades
15
Issuers
1
Estimated value
$4.58M
Buys / sales
0 / 9
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Halozyme Therapeutics, Inc. HALO | Exercise | Jun 3, 2026 | $120.7K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Jun 3, 2026 | $120.7K |
| Halozyme Therapeutics, Inc. HALO | Sale | Jun 3, 2026 | $26.55K |
| Halozyme Therapeutics, Inc. HALO | Sale | Jun 3, 2026 | $101.51K |
| Halozyme Therapeutics, Inc. HALO | Sale | Jun 3, 2026 | $137.47K |
| Halozyme Therapeutics, Inc. HALO | Sale | Jun 3, 2026 | $425.12K |
| Halozyme Therapeutics, Inc. HALO | Sale | Jun 2, 2026 | $226.93K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Jun 2, 2026 | $241.4K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Jun 2, 2026 | $241.4K |
| Halozyme Therapeutics, Inc. HALO | Sale | Jun 2, 2026 | $1.1M |
| Halozyme Therapeutics, Inc. HALO | Sale | Jun 1, 2026 | $106.88K |
| Halozyme Therapeutics, Inc. HALO | Sale | Jun 1, 2026 | $875.59K |
| Halozyme Therapeutics, Inc. HALO | Sale | Jun 1, 2026 | $369.14K |
| Halozyme Therapeutics, Inc. HALO | Exercise | Jun 1, 2026 | $241.4K |
| Halozyme Therapeutics, Inc. HALO Current | Exercise | Jun 1, 2026 | $241.4K |